TIAA CREF Investment Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$723K	Buy	552,246 +198,931	+56%	+$247K	﹤0.01%	2456
2018 Q4	$323K	Sell	353,315 -53,822	-13%	-$82.5K	﹤0.01%	2745
2018 Q3	$837K	Sell	407,137 -106,950	-21%	-$225K	﹤0.01%	2509
2018 Q2	$927K	Buy	514,087 +3,946	+0.8%	+$7.94K	﹤0.01%	2523
2018 Q1	$1.2M	Buy	510,141 +278,211	+120%	+$652K	﹤0.01%	2340
2017 Q4	$436K	Buy	231,930 +21,755	+10%	+$47.5K	﹤0.01%	2831
2017 Q3	$522K	Sell	210,175 -27,494	-12%	-$68.2K	﹤0.01%	2808
2017 Q2	$655K	Buy	237,669 +34,836	+17%	+$97.3K	﹤0.01%	2738
2017 Q1	$612K	Buy	202,833 +7,601	+4%	+$21.6K	﹤0.01%	2726
2016 Q4	$617K	Sell	195,232 -22,707	-10%	-$69.7K	﹤0.01%	2765
2016 Q3	$744	Sell	217,939 -17,985	-8%	-$49.7K	﹤0.01%	2684
2016 Q2	$539K	Buy	235,924 +29,887	+15%	+$73.3K	﹤0.01%	2826
2016 Q1	$517K	Sell	206,037 -17,382	-8%	-$38.8K	﹤0.01%	2773
2015 Q4	$739K	Hold	223,419	–	–	﹤0.01%	2751
2015 Q3	$541K	Hold	223,419	–	–	﹤0.01%	2864
2015 Q2	$655K	Buy	223,419 +13,963	+7%	+$54.1K	﹤0.01%	2884
2015 Q1	$840K	Hold	209,456	–	–	﹤0.01%	2714
2014 Q4	$631K	Sell	209,456 -9,805	-4%	-$26.5K	﹤0.01%	2885
2014 Q3	$556K	Sell	219,261 -14,954	-6%	-$36K	﹤0.01%	2930
2014 Q2	$577K	Buy	234,215 +27,763	+13%	+$62.7K	﹤0.01%	2979
2014 Q1	$548K	Hold	206,452	–	–	﹤0.01%	2913
2013 Q4	$600K	Buy	206,452 +18,610	+10%	+$56.2K	﹤0.01%	2910
2013 Q3	$576K	Buy	187,842 +6,457	+4%	+$20.4K	﹤0.01%	2894
2013 Q2	$580K	Buy	+181,385	New	+$581K	﹤0.01%	2885